Chorus vs Sofya

Chorus and Sofya are both business tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

Chorus

Chorus records and transcribes sales calls and meetings, then layers analysis on top: keyword scanning for competitor mentions and objections, talk-time ratios, question patterns, and deal-risk signals surfaced from rep behavior across the pipeline. For a sales org with ten or more reps running structured methodologies, the pitch is that managers stop relying on anecdote and start coaching from actual call moments. The CRM connection means deal timelines and conversation data travel together. The ceiling appears in smaller teams where the volume of calls does not justify the analytics overhead, and in orgs outside ZoomInfo's ecosystem where the integration story gets thinner.

Sofya

Sofya targets that gap: an AI layer built for healthcare workflows that handles patient intake, structures notes during consultations, and surfaces clinical decision support in real time. The vendor states full HIPAA and LGPD compliance, HL7 and FHIR integration, and self-hosted deployment for organizations that cannot let patient data leave their infrastructure. Where it fits cleanly is high-volume clinical environments already running compatible EHRs — the structured output lands directly into existing systems rather than creating a parallel documentation layer. The ceiling appears in smaller or more specialized clinical settings where the intake and decision-support logic does not map to the tool's pre-built workflows, and the custom pricing model means budget clarity requires a sales conversation before any technical evaluation.

Attribute	Chorus	Sofya
Pricing	Paid	Paid
Price	$20/month	—
Free trial	3 days	No
Open source	No	No
Has API	Yes	No
Self-hosted option	No	Yes
Platforms	Web, iOS, Android, Chrome Extension	Web, Phone, WhatsApp, EHR Integration
Released	2015	—
Pros	Automatic call recording and transcription across sales meetings, so managers are coaching from actual moments in a rep's calls rather than reconstructed summaries that miss what was actually said. Keyword and question scanning across large call libraries, which means product marketing can build competitive battlecards from real objection patterns instead of waiting for reps to manually log competitor mentions. Deal-risk and expansion signals surfaced from call behavior, so pipeline reviews are anchored to conversation evidence rather than rep-reported status that tends to be optimistic until the deal slips. Structured coaching workflows tied to call clips, so new hire ramp time shortens because the benchmark for 'good' is a library of actual winning calls rather than a manager's description of one. CRM-connected call analytics inside the ZoomInfo ecosystem, so conversation data and firmographic context travel together and deal timelines do not require manual reconciliation across two systems.	Real-time documentation structuring during consultations, so clinicians avoid the post-visit note backlog that typically extends work hours beyond patient-facing time. Native HL7 and FHIR compatibility, which means structured patient data flows into existing EHRs without a custom middleware build between Sofya and the records system. HIPAA and LGPD compliance built into the architecture, so legal and compliance review does not become a blocker after the technical evaluation is already complete. Self-hosted deployment option, so health systems with data residency mandates or air-gapped infrastructure requirements are not forced into a cloud dependency to use the tool. Multi-facility scaling described as a core design goal, which means a hospital system standardizing documentation across sites is working with the intended use case rather than stretching a single-clinic tool.
Cons	The analytics layer requires sustained call volume to surface reliable behavioral trends — teams with fewer than ten active reps or irregular meeting cadences generate a call library too thin to make the pattern analysis actionable, at which point the product is an expensive transcription service. Chorus is a paid-only tool with no free tier, and pricing is custom-quoted at the enterprise level; teams with tight budgets or a need to pilot before committing typically cannot test the product at production scale before signing a contract, which makes the evaluation process higher-stakes than competitors who offer trial access. The integration advantage is tightly coupled to existing ZoomInfo subscriptions — teams not already paying for ZoomInfo's data platform lose the cross-layer intelligence that differentiates Chorus from standalone conversation intelligence tools like Gong or Clari Copilot, and at that point those standalone tools are the direct alternative teams move to. There is no self-hosted deployment option, which is a hard blocker for enterprise security teams operating under data residency policies that prohibit third-party cloud recording of customer calls — those teams route around it by deploying an on-premises alternative or excluding certain call types from capture entirely.	Pricing is not disclosed publicly and requires direct vendor engagement to obtain — clinical IT teams cannot run a budget comparison or procurement estimate without entering a sales process first, which stalls evaluation timelines for organizations with formal RFP requirements. Self-hosted deployment is stated as available but carries no public documentation, container images, or self-service setup path; organizations expecting to spin up an instance independently before committing will find the implementation runs entirely through vendor-managed onboarding, which adds timeline and dependency risk. Decision support and intake automation are built around generalized clinical workflows — specialty practices with non-standard protocols (interventional radiology, behavioral health with jurisdiction-specific documentation requirements, for example) will hit configuration limits that the vendor's templated approach does not cover; at that point teams typically evaluate building custom integrations against an AI provider directly rather than adapting a purpose-built but inflexible product. The tool is a paid-only offering with no public free tier or sandbox environment visible on the vendor page, which means a clinical team cannot validate workflow fit before procurement — a significant friction point for organizations where clinical staff sign off on tooling decisions and expect hands-on evaluation before institutional commitment.

Bottom line

Only Chorus exposes a public API. Choose based on which difference matters most for your workflow.

Frequently asked questions

What is the difference between Chorus and Sofya?

Chorus is Paid, while Sofya is Paid. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is Chorus better than Sofya?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.

Chorus vs Sofya: which should I pick?

Pick Chorus if its pricing model, openness, or platform fit matches your constraints; pick Sofya otherwise. Check free-trial availability on each listing if you want to test before committing.

Comparison data is sourced and verified by the AIDiveForge data pipeline. AIDiveForge is editorially independent.